Skip to main content
Premium Trial:

Request an Annual Quote

Oncocyte: Jennifer Levin Carter

Oncocyte has appointed Jennifer Levin Carter to its board of directors. Carter is a healthcare executive, board member, and entrepreneur and was most recently VP and head of precision health at Integral Health. She has founded and served as CEO at healthcare companies including N-of-One, where she was CEO from 2008 to 2012 and chief medical officer from 2012 until its acquisition by Qiagen in 2019. In addition to her board appointment for Oncocyte, Carter serves as a director of DFP Healthcare Acquisitions and is on the board of directors of home healthcare firm HouseWorks, digital health company eCaring, and the Target Cancer Foundation. She is a founding strategic board member of XSphera Biosciences, and on the directors advisory board at Smilow Cancer Hospital at Yale University. 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.